P2X Purinoceptor 7 (P2Z Receptor or P2RX7): Pharmaceutical and Healthcare Pipeline Review, H2, 2017

Posted on 2017-07-31 by Mark Hub in Pharmaceuticals // 0 Comments

Albany, US, 2017-Jul-31 — /EPR Network/ — According to the Market Research Hub’s recently published report ‘P2X Purinoceptor 7 Pipeline Review, H2 2017‘ P2X Purinoceptor 7 (P2Z Receptor or P2RX7) pipeline Target constitutes close to 9 molecules. Out of which approximately 9 molecules are developed by Companies. P2X Purinoceptor 7 (P2Z Receptor or P2RX7) – P2X purinoceptor 7 is a protein encoded by the P2RX7 gene. It acts as receptor for ATP that acts as a ligand-gated ion channel. It is responsible for ATP-dependent lysis of macrophages through the formation of membrane pores permeable to large molecules.

Request Free Sample Report @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1256887

The report ‘P2X Purinoceptor 7 – Pipeline Review, H2 2017’ outlays comprehensive information on the P2X Purinoceptor 7 (P2Z Receptor or P2RX7) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type; that are being developed by Companies / Universities.

It also reviews key players involved in P2X Purinoceptor 7 (P2Z Receptor or P2RX7) targeted therapeutics development with respective active and dormant or discontinued projects. Currently, The molecules developed by companies in Phase II, Phase I, Preclinical and Discovery stages are 1, 2, 5 and 1 respectively. Report covers products from therapy areas Central Nervous System, Immunology, Oncology, Gastrointestinal, Genetic Disorders, Metabolic Disorders and Musculoskeletal Disorders which include indications Neuropathic Pain, Inflammation, Multiple Sclerosis, Alzheimer’s Disease, Autoimmune Disorders, Basal Cell Carcinoma (Basal Cell Epithelioma), Bipolar Disorder (Manic Depression), Charcot-Marie-Tooth Disease Type I A, Depression, Inflammatory Bowel Disease, Major Depressive Disorder, Mania, Muscular Dystrophy, Neurodegenerative Diseases, Osteoarthritis Pain, Psoriasis, Rheumatoid Arthritis, Solid Tumor, Systemic Lupus Erythematosus, Transplant Rejection, Type 1 Diabetes (Juvenile Diabetes) and Visceral Pain.

Scope:

– The report provides a snapshot of the global therapeutic landscape for P2X Purinoceptor 7 (P2Z Receptor or P2RX7)

– The report reviews P2X Purinoceptor 7 (P2Z Receptor or P2RX7) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources

– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

– The report reviews key players involved in P2X Purinoceptor 7 (P2Z Receptor or P2RX7) targeted therapeutics and enlists all their major and minor projects

– The report assesses P2X Purinoceptor 7 (P2Z Receptor or P2RX7) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type

– The report summarizes all the dormant and discontinued pipeline projects

– The report reviews latest news and deals related to P2X Purinoceptor 7 (P2Z Receptor or P2RX7) targeted therapeutics

Reasons to Buy:

– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand the targeted therapy areas and indications for P2X Purinoceptor 7 (P2Z Receptor or P2RX7)

– Identify the use of drugs for target identification and drug repurposing

– Identify potential new clients or partners in the target demographic

– Develop strategic initiatives by understanding the focus areas of leading companies

– Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics

– Devise corrective measures for pipeline projects by understanding P2X Purinoceptor 7 (P2Z Receptor or P2RX7) development landscape

– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Browse Full Report with TOC @ http://www.marketresearchhub.com/report/p2x-purinoceptor-7-p2z-receptor-or-p2rx7-pipeline-review-h2-2017-report.html

Table of Content:

List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
P2X Purinoceptor 7 (P2Z Receptor or P2RX7) – Overview
P2X Purinoceptor 7 (P2Z Receptor or P2RX7) – Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
P2X Purinoceptor 7 (P2Z Receptor or P2RX7) – Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
P2X Purinoceptor 7 (P2Z Receptor or P2RX7) – Companies Involved in Therapeutics Development
Affectis Pharmaceuticals AG
Axxam SpA
Biosceptre International Ltd
Evotec AG
Johnson & Johnson
Medestea Research & Production SpA
P2X Purinoceptor 7 (P2Z Receptor or P2RX7) – Drug Profiles
AFC-5128 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BIL-010t – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BIL-06v – Drug Profile

Make an Enquiry @ http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1256887

About Market Research Hub:

Market Research Hub (MRH) is a next-generation reseller of Research Reports and analysis. MRH’s expansive collection of pharmaceutical market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Matched content

Editor’s pick